Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)

NCT06721871 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Napo Pharmaceuticals, Inc.